TY  - JOUR
AU  - Romero-Miguel, Diego
AU  - Casquero-Veiga, Marta
AU  - MacDowell, Karina S
AU  - Torres-Sanchez, Sonia
AU  - Garcia-Partida, José Antonio
AU  - Lamanna-Rama, Nicolás
AU  - Romero-Miranda, Ana
AU  - Berrocoso, Esther
AU  - Leza, Juan C
AU  - Desco, Manuel
AU  - Soto-Montenegro, María Luisa
PY  - 2021
DO  - 10.1093/ijnp/pyab036
UR  - https://hdl.handle.net/10668/25231
T2  - The international journal of neuropsychopharmacology
AB  - Minocycline (MIN) is a tetracycline with antioxidant, anti-inflammatory, and neuroprotective properties. Given the likely involvement of inflammation and oxidative stress (IOS) in schizophrenia, MIN has been proposed as a potential adjuvant treatment...
LA  - en
KW  - FDG-PET
KW  - Poly I:C
KW  - inflammatory/oxidonitrosative stress
KW  - minocycline
KW  - schizophrenia
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Antioxidants
KW  - Behavior, Animal
KW  - Brain Diseases, Metabolic
KW  - Disease Models, Animal
KW  - Female
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Minocycline
KW  - Nervous System Malformations
KW  - Neurodevelopmental Disorders
KW  - Oxidative Stress
KW  - Positron-Emission Tomography
KW  - Pregnancy
KW  - Prenatal Exposure Delayed Effects
KW  - Prepulse Inhibition
KW  - Rats
KW  - Rats, Wistar
KW  - Schizophrenia
TI  - A Characterization of the Effects of Minocycline Treatment During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders.
TY  - research article
VL  - 24
ER  -